Skip to content

Model 492-02 Endocardial Pacing Lead

by Intermedics, Inc. 510(k)

Active United States

510(k) K860548

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK860548 Date13 Jun 1986ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Model 492-02 Endocardial Pacing Lead is a Permanent Pacemaker Electrode, designed for endocardial stimulation within the heart. It delivers electrical impulses to regulate cardiac rhythm in patients requiring permanent pacing support, typically for bradycardia or conduction disorders. The lead is intended for implantation within the right ventricle or atrium to ensure precise pacing and synchronization of heart contractions.

This device is supplied sterile and intended for single-use implantation by qualified healthcare professionals in a clinical setting. It is classified as a Class III medical device under FDA regulations and has received FDA 510K clearance as substantially equivalent to predicate devices. The lead is compatible with standard pacemaker systems and must be handled under aseptic conditions prior to use, with storage adhering to manufacturer guidelines to maintain sterility and functionality.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Model 492-02 Endocardial Pacing Lead, and where is it typically implanted within the body?

    The Model 492-02 Endocardial Pacing Lead is designed to deliver electrical impulses for endocardial stimulation, helping regulate cardiac rhythm in patients who require permanent pacing support. It is specifically intended for implantation within the right ventricle or atrium of the heart to ensure precise pacing and synchronization of heart contractions, particularly for conditions like bradycardia or conduction disorders.

  • Is the Model 492-02 Endocardial Pacing Lead meant for single-use or reusable applications, and how should it be stored to maintain sterility?

    The Model 492-02 Endocardial Pacing Lead is supplied sterile and intended for single-use implantation only. To maintain sterility and functionality, it must be handled under aseptic conditions before use and stored according to the manufacturer’s guidelines, which are detailed in the accompanying documentation.

  • What regulatory pathway was followed for FDA clearance of this device, and which advisory committee was involved?

    The Model 492-02 Endocardial Pacing Lead received FDA 510K clearance through a traditional review pathway, determined to be substantially equivalent to predicate devices. The submission was reviewed by the Cardiovascular (CV) Advisory Committee, reflecting its classification as a Class III medical device under FDA regulations.

  • Can this lead be used with standard pacemaker systems, and what precautions should be taken during handling?

    Yes, the Model 492-02 Endocardial Pacing Lead is compatible with standard pacemaker systems. However, it must be handled under aseptic conditions prior to implantation, as it is a sterile, single-use device. Adherence to manufacturer storage instructions is critical to preserve its sterility and functionality.